By Azhar Khan•1 year agoJoin Amgen as an Associate Software Engineer - Full Stack Developer, based in Hyderabad, India. In this role, you'll design, develop, and maintain software applications, ensuring the performance and availability of critical systems. Collaborate with product managers, designers, and engineers to build high-quality, scalable solutions. This position offers an opportunity to work with the latest technologies, including cloud technology, generative AI, and microservices architecture.
We seek professionals with a passion for serving patients and strong technical skills in software development. The ideal candidate will demonstrate proficiency in programming languages such as Python and JavaScript, excellent problem-solving skills, and experience with cloud and microservices architecture.
We require a Bachelor’s degree in Computer Science, IT, or a related field with 0 to 3 years of experience, or a Diploma with 4 to 7 years of experience.
Recent graduates from the batch years 2022 to 2024 are eligible to apply.
If an employer asks you to pay any kind of fee, please notify us immediately. Talentd does not charge any fee from applicants and we do not allow other companies to do so.
Amgen Inc. is a leading multinational biotechnology company headquartered in Thousand Oaks, California, USA. Founded in 1980, Amgen is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its mission is to serve patients by transforming scientific discoveries into medicines that improve lives, with a focus on areas such as oncology, cardiovascular disease, neuroscience, and inflammation. The company is recognized for pioneering biologics and leveraging advanced genetic research to address serious illnesses.
With over 25,000 employees worldwide, Amgen holds a strong position in the global biotech market, consistently ranking among the largest biotechnology firms by revenue. It has a diverse portfolio of approved medicines, including well-known biologics like Enbrel, Neulasta, and Prolia, as well as a robust pipeline of investigational therapies. Recently, Amgen has made headlines for strategic acquisitions, such as its purchase of Horizon Therapeutics in 2023, expanding its rare disease portfolio, and for advancing cutting-edge research in biosimilars and precision medicine. The company is also committed to sustainability and corporate responsibility, aiming to reduce its environmental footprint while maintaining high standards of scientific excellence.
Websiteamgen.com
